the risk of stopping aspirin, clopidogrel, or other antiplatelet drugs too soon
September 2011
Patients often don't realize the risk of stopping aspirin, clopidogrel, or other antiplatelet drugs too soon.
Patients on aspirin for secondary prevention...or on aspirin plus clopidogrel for acute coronary syndrome or after a stent...sometimes stop these drugs on their own with dire consequences.
For example, stopping aspirin in patients with a prior MI leads to 4 extra MIs per 1000 patients per year.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote